YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.

doi:10.1111/j.1478-3231.2011.02686.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.

Liver international : official journal of the International Association for the Study of the Liver - 1 Apr 2012

Fontana Robert J, Litman Heather J, Dienstag Jules L, Bonkovsky Herbert L, Su Grace, Sterling Richard K, Lok Anna S

Abstract excerpt

BACKGROUND/AIMS: The aim of this study was to explore the association of a functional YKL-40 promoter polymorphism (rs4950928) with baseline disease stage, response to antiviral therapy and risk of liver disease progression in a group of patients with chronic hepatitis C (CHC). METHODS: YKL-40 promoter polymorphisms were determined in 456 Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chitinase-3-Like Protein 1

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Lectins

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 22103814
DOI: 10.1111/j.1478-3231.2011.02686.x
PMCID: PMC3299849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.PMID 22103814Read ↗

YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.Semantic proximity Read ↗

YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies.Semantic proximity Read ↗

Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway.Semantic proximity Read ↗

A polymorphism associated with increased levels of YKL-40 and the risk of early onset of lone atrial fibrillation.Semantic proximity Read ↗

PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression.Semantic proximity Read ↗

IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.Semantic proximity Read ↗

IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.